SCHEMBL9179221

SCHEMBL9179221

NCC(O)(c1ccccc1)c1cccc2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.46
HPGD P15428 3/20 0.44
HSD17B10 Q99714 3/20 0.44
CYP2C19 P33261 2/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
HIF1A Q16665 1/20 0.44
CFTR P13569 1/20 0.39
GOPC Q9HD26 1/20 0.39
ACP3 P15309 2/20 0.39
CYP3A4 P08684 2/20 0.37
TSHR P16473 2/20 0.37
TAAR1 Q96RJ0 2/20 0.37
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
GAA P10253 2/20 0.36
MAPT P10636 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16721031 0.83 CYP2C19 (0.44) KIF11HPGDHSD17B10CYP2C19CYP1A2
SCHEMBL453396 0.77 TAAR1 (0.52) KIF11CYP2C19CYP1A2CYP2D6CYP2C9
SCHEMBL27684720 0.76 KIF11 (0.43) KIF11HPGDHSD17B10CYP2C19CYP1A2
SCHEMBL10804024 0.76 CYP1A2 (0.41) KIF11HPGDHSD17B10CYP2C19CYP1A2
SCHEMBL25710684 0.76 HSD17B10 (0.65) KIF11HPGDHSD17B10CYP2C19CYP1A2
SCHEMBL2355481 0.76 CYP1A2 (0.59) KIF11HPGDHSD17B10CYP2C19CYP1A2
Hydrochloric Acid SCHEMBL10684188 0.75 SMN1; SMN2 (0.50) KIF11CYP2C19CYP1A2CYP2D6CYP2C9
SCHEMBL27684804 0.73 KIF11 (0.41) KIF11HPGDHSD17B10CYP2C19CYP1A2
SCHEMBL7217419 0.73 KIF11 (0.41) KIF11HPGDHSD17B10CYP2C19CYP1A2
SCHEMBL145926 0.73 KCNH2 (0.38) KIF11HPGDHSD17B10CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0650368-A1 USE OF CALPAIN INHIBITORS IN THE INHIBITION AND TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH INCREASED CALPAIN ACTIVITY CORTEX PHARMACEUTICALS, INC. (US) 1995-05-03 EP disclosed
WO-1994000095-A2 USE OF CALPAIN INHIBITORS IN THE INHIBITION AND TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH INCREASED CALPAIN ACTIVITY CORTEX PHARMACEUTICALS, INC. (US) 1994-01-06 WO disclosed